Insider Trading History of Nash David

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Nash David since 2012. The trader's CIK number is 1251968. At the time of the last reporting, Nash David was the Director of Ani Pharmaceuticals Inc. (stock ticker symbol ANIP). Also see all insider trading activities at Ani Pharmaceuticals Inc.

Note that in the past NASH DAVID also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Ani Pharmaceuticals Inc (ANIP) by Nash David

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 ANIP 1,445 $99,358 0 $0 0 $0

Yearly summary of insider trading at Humana Inc (HUM) by Nash David

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 HUM 112 $9,848 0 $0 0 $0

Yearly summary of insider trading at Endo Pharmaceuticals Holdings Inc (ENDP) by Nash David

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 ENDP 670 $20,636 0 $0 0 $0


Insider trading activities at 3 companies by Nash David:

1. Ani Pharmaceuticals Inc (ANIP)

2. Humana Inc (HUM)

3. Endo Pharmaceuticals Holdings Inc (ENDP)

Table 1. Insider trading of Ani Pharmaceuticals Inc (ANIP) by Nash David

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-05-24 ANIP Buy 1,445 68.76 99,358

Table 2. Insider trading of Humana Inc (HUM) by Nash David

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-03-28 HUM Buy 112 87.93 9,848

Table 3. Insider trading of Endo Pharmaceuticals Holdings Inc (ENDP) by Nash David

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-03-05 ENDP Buy 670 30.80 20,636

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nash David (Director of Ani Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.